Natalie Elizabeth Rose Hart, MS, CF-SLP | |
1 E Clark Bass Blvd, Mcalester, OK 74501-4209 | |
(918) 448-4471 | |
(918) 421-6612 |
Full Name | Natalie Elizabeth Rose Hart |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1 E Clark Bass Blvd, Mcalester, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467177956 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | CF427 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Natalie Elizabeth Rose Hart, MS, CF-SLP 1 E Clark Bass Blvd, Mcalester, OK 74501-4209 Ph: (918) 448-4471 | Natalie Elizabeth Rose Hart, MS, CF-SLP 1 E Clark Bass Blvd, Mcalester, OK 74501-4209 Ph: (918) 448-4471 |
News Archive
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
VITAS, the nation's leading hospice provider, is now serving patients with life-limiting diagnoses and their families in the greater Columbus area, including those in Delaware, Fairfield, Franklin, Licking, Madison, Pickaway and Union counties. VITAS also provides quality, compassionate end-of-life care in Ohio to patients and families in Cleveland, Cincinnati and Dayton.
A new paper that challenges widely held ideas about autism has attracted comments from more than 30 scholars across the disciplines of psychology, anthropology, education, and neuroscience.
Severin Schwan thinks the skeptics are wrong. Those who shun the pharmaceutical sector for its lack of prospects don't understand the potential created by a rapidly growing understanding of genetics and molecular biology, and the new drugs that will follow. ... the chief executive of Roche Holding AG, the world's seventh-largest drug firm by sales, is an informed optimist.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a novel histone deacetylase (HDAC) inhibitor.
› Verified 3 days ago
Mrs. Madison Walker, M.S. Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 | |
Madelyn Rebekah Stanfield, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 | |
Landry Rehabilitation, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Country Club Rd, Mcalester, OK 74501 Phone: 918-429-6734 | |
Melissa Lucille Byrum, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 E Cherokee Ave, Mcalester, OK 74501 Phone: 405-641-3534 | |
Joanne Ruth Hess, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 E Clark Bass Blvd, Mcalester, OK 74501 Phone: 918-426-1800 | |
Michaela Sky Mass, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 Fax: 918-423-2620 | |
Kelbie Moon, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 |